Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

Thumbnail

[VIDEO] Building a Protected PCI Program: The Community Hospital Approach

Offered in cooperation with Abiomed

Bakersfield Heart Hospital was as an early adopter of Abiomed’s Impella 2.5 miniature temporary ventricular assist device and now has expanded its use in elective and urgent high-risk PCI procedures.

Thumbnail

Acute kidney injury is common in patients undergoing vascular surgery

Nearly half of patients undergoing vascular surgery had perioperative acute kidney injury, which was associated with an increased risk for cardiovascular mortality, according to a 10-year analysis of procedures at a tertiary care teaching hospital.

Thumbnail

Society of Thoracic Surgeons releases CABG guidelines

Clinicians performing CABG should use arteries from the chest and forearm instead of veins from the leg in certain patients, according to guidelines from the Society of Thoracic Surgeons (STS).

Thumbnail

Boston Scientific voluntarily recalls the Chariot guiding sheath

Boston Scientific announced on Dec. 9 that it had voluntarily recalled its Chariot guiding sheath after receiving 14 complaints of shaft separation. The FDA classified it as a Class 1 recall, which is the most serious type of recall.

Renal dysfunction before CABG increases costs and healthcare utilization

A database analysis found that patients undergoing CABG had higher costs and hospital resource utilization if they had renal dysfunction before undergoing surgery.

Thumbnail

Registry provides real world data on TAVR procedures

The Nov. 30 release of data from a transcatheter aortic valve replacement (TAVR) registry provided clinicians, patients and payers with robust, real world information on a procedure that’s becoming more popular.

ACC and STS release data on TAVR procedures in the U.S. from 2012 to 2014

Patients who underwent transcatheter aortic valve replacement (TAVR) in the U.S. from 2012 to 2014 tended to be at least 80 years old and have multiple comorbidities, a high predicted risk of mortality and a poor self-reported health status, according to a registry analysis.

Thumbnail

Meril: Live at TCT. What’s New? What’s Next?

Meril

Hear what’s new from Meril's vice president, Sanjeev Bhatt, on tapered drug eluting stents, bioabsorbable scaffolds, dilatation catheters and TAVR.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.